DE60313640D1 - 1-(indol-3-yl)carbonyl piperazinderivate - Google Patents

1-(indol-3-yl)carbonyl piperazinderivate

Info

Publication number
DE60313640D1
DE60313640D1 DE60313640T DE60313640T DE60313640D1 DE 60313640 D1 DE60313640 D1 DE 60313640D1 DE 60313640 T DE60313640 T DE 60313640T DE 60313640 T DE60313640 T DE 60313640T DE 60313640 D1 DE60313640 D1 DE 60313640D1
Authority
DE
Germany
Prior art keywords
indol
piperazine derivatives
carbonyl piperazine
carbonyl
derivatives
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE60313640T
Other languages
English (en)
Other versions
DE60313640T2 (de
Inventor
Phillip Martin Cowley
Wilson Caulfield
Jason Tierney
James Cairns
Julia Adam-Worrall
Mark York
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Organon NV
Original Assignee
Organon NV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Organon NV filed Critical Organon NV
Application granted granted Critical
Publication of DE60313640D1 publication Critical patent/DE60313640D1/de
Publication of DE60313640T2 publication Critical patent/DE60313640T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/08—Drugs for disorders of the alimentary tract or the digestive system for nausea, cinetosis or vertigo; Antiemetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
    • C07D209/04—Indoles; Hydrogenated indoles
    • C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
    • C07D209/42—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Hospice & Palliative Care (AREA)
  • Cardiology (AREA)
  • Anesthesiology (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Otolaryngology (AREA)
  • Nutrition Science (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Indole Compounds (AREA)
DE60313640T 2002-06-21 2003-06-13 1-(indol-3-yl)carbonyl piperazinderivate Expired - Lifetime DE60313640T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP02077505 2002-06-21
EP02077505 2002-06-21
PCT/EP2003/050226 WO2004000832A1 (en) 2002-06-21 2003-06-13 1-[(indol-3-yl)carbonyl] piperazine derivatives

Publications (2)

Publication Number Publication Date
DE60313640D1 true DE60313640D1 (de) 2007-06-14
DE60313640T2 DE60313640T2 (de) 2007-12-27

Family

ID=29797228

Family Applications (1)

Application Number Title Priority Date Filing Date
DE60313640T Expired - Lifetime DE60313640T2 (de) 2002-06-21 2003-06-13 1-(indol-3-yl)carbonyl piperazinderivate

Country Status (33)

Country Link
US (1) US7304064B2 (de)
EP (1) EP1549637B1 (de)
JP (1) JP4408804B2 (de)
KR (1) KR20050009755A (de)
CN (1) CN1298716C (de)
AR (1) AR040274A1 (de)
AT (1) ATE361290T1 (de)
AU (1) AU2003250245B2 (de)
BR (1) BR0311960A (de)
CA (1) CA2490141C (de)
CO (1) CO5680419A2 (de)
CY (1) CY1107677T1 (de)
DE (1) DE60313640T2 (de)
DK (1) DK1549637T3 (de)
EC (1) ECSP045503A (de)
ES (1) ES2285183T3 (de)
HK (1) HK1076630A1 (de)
HR (1) HRP20041186A2 (de)
IL (1) IL165572A0 (de)
IS (1) IS2443B (de)
MX (1) MXPA04012856A (de)
NO (1) NO20045351L (de)
NZ (1) NZ537143A (de)
PE (1) PE20040578A1 (de)
PL (1) PL375152A1 (de)
PT (1) PT1549637E (de)
RS (1) RS111104A (de)
RU (1) RU2318821C2 (de)
SI (1) SI1549637T1 (de)
TW (1) TW200402417A (de)
UA (1) UA78317C2 (de)
WO (1) WO2004000832A1 (de)
ZA (1) ZA200410057B (de)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TWI242015B (en) 1999-11-29 2005-10-21 Akzo Nobel Nv 6-mercapto-cyclodextrin derivatives: reversal agents for drug-induced neuromuscular block
ATE375349T1 (de) 2002-08-02 2007-10-15 Merck & Co Inc Substituierte furo(2,3-b)pyridin derivate
DE10253426B4 (de) 2002-11-15 2005-09-22 Elbion Ag Neue Hydroxyindole, deren Verwendung als Inhibitoren der Phosphodiesterase 4 und Verfahren zu deren Herstellung
AU2004298782B2 (en) * 2003-12-17 2010-06-17 Merck Sharp & Dohme B.V. Tricyclic 1-[(3-indol-3-yl)carbonyl] piperazine derivatives as cannabinoid CB1 receptor agonists
TWI330635B (en) * 2004-03-05 2010-09-21 Organon Nv (indol-3-yl)-heterocycle derivatives
JP2009500439A (ja) * 2005-07-11 2009-01-08 ナームローゼ・フエンノートチヤツプ・オルガノン 疼痛の治療のための相乗的組み合わせ（カンナビノイド受容体アゴニスト及びオピオイド受容体アゴニスト）
CA2616937A1 (en) * 2005-07-29 2007-02-08 F. Hoffman-La Roche Ag Indol-3-yl-carbonyl-piperidin and piperazin derivatives
TW200745096A (en) * 2005-08-23 2007-12-16 Organon Nv Indole derivatives
US7763732B2 (en) 2005-08-24 2010-07-27 N.V. Organon Indole derivatives
EA200800888A1 (ru) * 2005-09-23 2009-02-27 Янссен Фармацевтика Н.В. Модуляторы каннабиноидов на основе замещенных 3-амидотетрагидроиндазолилов
TW200848417A (en) 2007-02-22 2008-12-16 Organon Nv Indole derivatives
RU2387642C2 (ru) 2007-10-31 2010-04-27 Общество С Ограниченной Ответственностью "Бинатех" Производные 5-замещенных индол-3-карбоновой кислоты, обладающие противовирусной активностью, способ их получения и применение
GB201106817D0 (en) 2011-04-21 2011-06-01 Astex Therapeutics Ltd New compound
NZ758528A (en) 2013-12-20 2022-05-27 Astex Therapeutics Ltd Bicyclic heterocycle compounds and their uses in therapy
EP3737680A1 (de) * 2018-01-08 2020-11-18 F. Hoffmann-La Roche AG Octahydropyrido[1,2-alpha]pyrazine als magl-inhibitoren
CN108752342A (zh) * 2018-08-17 2018-11-06 西安瑞联新材料股份有限公司 1-H-吡啶并[1,2-a]-6-氢吡嗪-1,4-二酮的制备方法
CN111100063B (zh) * 2018-10-25 2022-05-17 南京药石科技股份有限公司 一种合成2-氟甲基取代的吡咯烷、哌啶以及哌嗪衍生物的制备方法

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998006715A1 (en) 1996-08-09 1998-02-19 Smithkline Beecham Corporation Novel piperazine containing compounds
EP1243268A4 (de) 1999-12-14 2003-05-21 Nippon Shinyaku Co Ltd Medizinische zusammenstellung
AU2001234958A1 (en) * 2000-02-11 2001-08-20 Bristol-Myers Squibb Company Cannabinoid receptor modulators, their processes of preparation, and use of cannabinoid receptor modulators for treating respiratory and non-respiratory diseases

Also Published As

Publication number Publication date
HRP20041186A2 (en) 2005-06-30
AU2003250245B2 (en) 2008-07-03
ECSP045503A (es) 2005-03-10
US20050250760A1 (en) 2005-11-10
AU2003250245A1 (en) 2004-01-06
RS111104A (en) 2007-02-05
CN1668611A (zh) 2005-09-14
DE60313640T2 (de) 2007-12-27
DK1549637T3 (da) 2007-07-16
RU2318821C2 (ru) 2008-03-10
CA2490141A1 (en) 2003-12-31
ZA200410057B (en) 2005-10-20
SI1549637T1 (sl) 2007-10-31
CN1298716C (zh) 2007-02-07
TW200402417A (en) 2004-02-16
HK1076630A1 (en) 2006-01-20
IS7590A (is) 2004-12-09
KR20050009755A (ko) 2005-01-25
PT1549637E (pt) 2007-05-31
NZ537143A (en) 2005-05-27
RU2005101349A (ru) 2005-06-27
ES2285183T3 (es) 2007-11-16
WO2004000832A1 (en) 2003-12-31
CO5680419A2 (es) 2006-09-29
ATE361290T1 (de) 2007-05-15
AR040274A1 (es) 2005-03-23
UA78317C2 (en) 2007-03-15
US7304064B2 (en) 2007-12-04
JP2005533801A (ja) 2005-11-10
PE20040578A1 (es) 2004-09-15
MXPA04012856A (es) 2005-03-31
NO20045351L (no) 2005-01-20
EP1549637A1 (de) 2005-07-06
PL375152A1 (en) 2005-11-28
CY1107677T1 (el) 2013-04-18
CA2490141C (en) 2011-01-25
IL165572A0 (en) 2006-01-15
IS2443B (is) 2008-11-15
JP4408804B2 (ja) 2010-02-03
EP1549637B1 (de) 2007-05-02
BR0311960A (pt) 2005-03-22

Similar Documents

Publication Publication Date Title
HK1076630A1 (en) 1-(Indol-3-yl) carbonyl piperazine derivatives
DK1490355T3 (da) Indolylmaleimidderivater
DE60336314D1 (de) Substituierte indole
DK1515969T3 (da) Spiroindolinpiperidinderivater
DE60301683D1 (de) Leseverstärker
DK1556385T3 (da) Heterocyclocarboxamid-derivater
ATE450506T1 (de) Indol-3-schwefelderivate
ATE467631T1 (de) Chinuclidinamidderivate
IS7720A (is) Píperidín-N-oxíð-afleiður
DK2248807T3 (da) N-Phenyl-2-pyrimidinaminderivater
DK1472255T3 (da) Aza-arylpiperaziner
IS7667A (is) Nýjar bensimídazólafleiður
IS7599A (is) Heterósýklískir kínasatálmar
ATE499347T1 (de) Amidderivate
NO20052487D0 (no) 1-(4-benzyl-piperazin-1-yl)-3-fenyl-propenonderivater.
NO20045064L (no) Indol-, azaindol- og beslektede heterocykliske 4-alkenyl-piperidin-amider
ATE308543T1 (de) Piperidinderivate
ATE386518T1 (de) Benzimidazolderivate
DE60307512D1 (de) 3h-chinazoline -4-on derivaten
ATE423771T1 (de) Tetrahydrochinolinderivate
IS8002A (is) Setið indólín og indól afleiður
NO20035672D0 (no) Nye indolderivater
IS7906A (is) Afleiður própargýl-tríflúorómetoxý-amínó-benzóþíazóls
NO20052413D0 (no) Substituted aralkyl derivatives
DE60323130D1 (de) Indolderivaten

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
R082 Change of representative

Ref document number: 1549637

Country of ref document: EP

Representative=s name: WUESTHOFF & WUESTHOFF PATENT- UND RECHTSANWAEL, DE